The US requires health care providers to stop using some Chinese pharmaceutical syringes Haiou due to poor quality.

The US Food and Drug Administration (FDA) (FDA) recommends not to use 1ml syringe with 25GX1 needles and 1ml syringe with a 23gx1 needle produced by China's Haiou Medical Apparatus company.

FDA said it has received a report on the low quality issue of these two types of syringes, including the needle falling from the tube, getting into patient arms or some incidents that cause injury to care workers

An elderly who was vaccinated in New Mexico, the US in April. Photo: Reuters.

FDA spokesman added that these syringes have been stopped transporting with Vaccine Covid-19 vaccination kits in the US from March 22.

Erin Fox, senior director of pharmaceuticals at Utah Medical University, said each received these syringes came with Pfizer / Biontech vaccine plots as part of the vaccination kit.

FDA since April 30 issued imports warning with Chinese company syringes to prevent them from being put into the United States.

US President Joe Biden declared 80 million doses of Vaccine Covid-19 for countries in the next 6 weeks through the Covax support program, 5 times any of this country.